Lilly Looks For Sepsis Biomarkers That Could Aid Xigris Administration

Studies are underway to support the use of protein C as a biomarker, Lilly Senior Medical Director for Cardiovascular & Acute Care Macias tells a recent CDER seminar. Data suggest Xigris, a form of activated protein C, has higher survival rates when administered early. Biomarkers could be a signal for use.